Skip to content
10-Q

Quarterly Report

LISATA THERAPEUTICS, INC. LSTA

0000320017-26-000032

← back to feed
Filed
May 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 9.11M sh
Shares Diluted Q1 2026 · Mar 31, 2026 9.01M sh
Shares Diluted Q1 2026 · Mar 31, 2025 8.6M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $28K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$3.08M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$5.4M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $13.06M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $15.96M
Stockholders Equity Q1 2026 · Mar 31, 2026 $10.93M
Stockholders Equity Q1 2026 · Dec 31, 2025 $14.86M
Current Liabilities Q1 2026 · Mar 31, 2026 $3.32M
Current Liabilities Q1 2026 · Dec 31, 2025 $3.07M
Total Liabilities Q1 2026 · Mar 31, 2026 $3.39M
Total Liabilities Q1 2026 · Dec 31, 2025 $3.14M
Current Assets Q1 2026 · Mar 31, 2026 $14.02M
Current Assets Q1 2026 · Dec 31, 2025 $17.7M
Total Assets Q1 2026 · Mar 31, 2026 $14.06M
Total Assets Q1 2026 · Dec 31, 2025 $17.74M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.50
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.55
Eps Basic Q1 2026 · Mar 31, 2026 −$0.50
Eps Basic Q1 2026 · Mar 31, 2025 −$0.55
Net Income Q1 2026 · Mar 31, 2026 −$4.49M
Net Income Q1 2026 · Mar 31, 2025 −$4.72M
Operating Income Q1 2026 · Mar 31, 2026 −$4.94M
Operating Income Q1 2026 · Mar 31, 2025 −$5.85M
Revenue Q1 2026 · Mar 31, 2026 $0
Revenue Q1 2026 · Mar 31, 2025 $0